Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma.
Saved in:
| Title: | Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma. |
|---|---|
| Authors: | Grischke TK; Indiana University School of Medicine, Fort Wayne, IN, USA., Cooperrider JH; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Pula A; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.; Department of Hematology, Medical University of Lodz, Lodz, Poland., Sneider A; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Yates S; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Jakubowiak AJ; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA., Derman BA; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. bderman@bsd.uchicago.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Mar 28; Vol. 15 (1), pp. 47. Date of Electronic Publication: 2025 Mar 28. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
